The global therapeutic diet for pet market reflects a remarkable trajectory from 2024 to 2034, indicating a robust growth rate. After a thorough survey, the market growth equates to a sluggish CAGR of 4.0% during the forecast period. With an initial forecast of US$ 502.4 million in 2024, the market is witnessing a significant increase to US$ 744.5 million by 2034.
| Attributes | Key Insights |
|---|---|
| Therapeutic Diet for Pet Market Size (2024E) | US$ 502.4 million |
| Therapeutic Diet for Pet Industry Value (2034F) | US$ 744.5 million |
| Value-based CAGR (2024 to 2034) | 4.0% |
Rising pet ownership rates and consumer spending on veterinary meals tailored to individual pet health needs are fueling market growth. The United States and Europe have leading dog populations due to their developing pet ecosystems and accessibility to adoption & purchase from animal shelters.
Pet owners worldwide are looking for more personalized nutrition solutions for their pets, which is surging the demand for therapeutic diets that cater to individual pet health needs, preferences, and dietary restrictions. Also, ongoing research and studies on pet nutrition & related science, ingredient technology developments, and product formulations are fueling growth and innovation in the market.
Consulting with a veterinarian is essential for determining the most suitable therapeutic diet for each pet's unique health requirements. By providing tailored nutrition and adhering to veterinarian recommendations, pet owners can significantly enhance their furry companions' quality of life and longevity. Furthermore, the market is growing due to the rise in pet digestive issues and increasing concern for dental & oral health issues in dogs.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for therapeutic diets for pets is divined to develop rapidly. The historical CAGR of 2.6% was recorded for the market, and a 4.0% CAGR is estimated through 2034. The veterinary field has advanced, and evaluation of pet dietary requirements, particularly those with specific medical issues, has increased.
Veterinarians, as key influencers, are increasingly suggesting therapeutic diets as part of treatment regimens for various illnesses, underscoring the main role of pet food producers and manufacturers in meeting these evolving needs. Several pet owners recognized the importance of diet in maintaining their animals' health, with growing demand for therapeutic diets to address common health disorders like obesity, diabetes, and food allergies.
From 2019 to 2023, pet food producers and manufacturers invested in research & development to create unique therapeutic diets catering to specific pet health needs. This includes using progressive ingredients, innovative formulation methods, and empirical research to prevent the growth of diseases like dental or joint problems.
The demand for personalized pet food is increasing, propelled by pet owners' specific dietary needs and health conditions, leading to the development of specialized formulations. E-commerce platforms are projected to gain traction in the market amid increasing online pet food sales due to easy and direct home delivery in less time.
Pet owners are demonstrating a heightened sense of responsibility toward their pets' health and well-being, leading to a growing demand for specialized therapeutic diets to address specific health conditions and nutritional needs. This trend is a testament to the evolving pet care landscape, where owners are increasingly motivated to provide the best possible care for their beloved companions.
The rising number of pets is increasingly seen as a sign of wealth and sophistication in society, particularly in the United States and Europe. The trend toward grain-free and gluten-free pet food continues to grow, propelled by concerns over pet allergies and digestive issues.
Principal Consultant
According to statistical data, industries in the United Kingdom and the United States are envisioned to develop relatively well in the next decade. Meanwhile, the industry in Germany and China is experiencing a substantial shift due to various factors. The industry in India is also anticipated to mature extensively in the upcoming decade.
| Countries | Market Value (2034) |
|---|---|
| United States | US$ 305.6 million |
| United Kingdom | US$ 23.5 million |
| Germany | US$ 26.1 million |
| China | US$ 19.7 million |
| India | US$ 10.8 million |
The table below shows the estimated growth rates of the leading five countries. The United States, the United Kingdom, and Germany are set to record CAGRs of 5.1%, 4.3%, and 4.0%, respectively, through 2034.
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 5.1% |
| United Kingdom | 4.3% |
| Germany | 4.0% |
| China | 3.8% |
| India | 3.5% |
Pet owners are increasingly focused on preventive health care for their pets, fueling the demand for therapeutic diets that support immune function, digestive health, and disease prevention. Millennials in the United States are very concerned about pet health and always look for better food products and medicated treatment for faster results.
Consumers in the United States tend to spend a lot on their pet's medical treatment to fight allergies and age-related issues. The rise in pet obesity in the United States has led to a growing need for specialized therapeutic diets designed to manage weight and support healthy weight loss in pets. Nowadays, allergies are common in pets, and demand for hypoallergenic therapeutic diets that address food sensitivities and skin issues is on the rise.
With an aging pet population in the United States, there is a growing need for therapeutic diets that support joint health, cognitive function, and wellness in senior pets. For instance, Farmina Vet Life Diabetic is a complete diabetic food for adult dogs, suggested for the regulation of glucose supply (diabetes mellitus) and the reduction of excessive body weight.
Growing health issues among pets, such as excessive gas, skin irritation, loose stools, and various ear & skin infections, propel the demand for a therapeutic diet for pets. A therapeutic diet for pets promotes a healthy, shiny coat with soft skin, enhances digestive & immune systems, and is beneficial for pet owners.
Manufacturers in Germany are investing in research & development to produce quality products and increase the nutritional value of pet food. Pet owners are increasingly spending on healthy pet foods due to surging awareness of intolerances and allergies. The demand for hypoallergenic pet food combinations has risen by 75%, with suppliers incorporating omega-3 fatty acids and diabetic products into their offerings.
Pet ownership in China is increasing, with several owners viewing their pets as part of the family. This has led to rising spending on veterinary care, including specialist diets.
Pet owners are becoming more aware of diet's role in maintaining their animals' health and treating various ailments. Veterinarians are increasingly recommending specialized diets as part of therapy regimens for certain diseases, fueling demand for therapeutic diets for pets in China.
Pet food manufacturers in India are constantly innovating to meet the nutritional needs of pets with health concerns. They use innovative ingredients and formulas supported by empirical data.
With the growth of e-commerce, pet owners have access to a wide range of therapeutic meals, offering greater convenience and a wider selection than traditional stores in India. Humanization of pets has led to a greater willingness to invest in specialized, high-quality items like therapeutic diets, ensuring pet’s health and well-being.
The segmented therapeutic diet for pet market analysis is included in the following subsection. Based on comprehensive studies, the cat segment is prevailing in the age group category. Similarly, the kidney disease segment is governing the health condition category.
| Segment | CAGR (2024 to 2034) |
|---|---|
| Cat (Age Group) | 4.6% |
| Kidney Disease (Health Condition) | 2.8% |
E-commerce platforms are surging globally, making the process of purchasing products easier and more informative for pet owners. Customers are becoming more concerned about product specifications. Online buying options offer various options, surpassing consumer demand.
Direct doorstep delivery, minimal charges, and emerging online distribution channels are the key factors fueling demand for therapeutic diets for pets through online distribution channels. Online platforms also provide detailed product solutions & comparisons, nutritional information, and customer reviews. These help pet owners compare brands, products, and ingredients quantity.
Pet food manufacturers are developing prescription diets for animals with kidney disease, limiting certain nutrients like protein and phosphorus to reduce kidney strain. This innovation is based on ongoing research and veterinarian advice, enhancing their products' nutritional balance, palatability, and efficacy.
Chronic kidney disease is a prevalent condition in senior dogs and cats. As pets live longer, the need for therapeutic diets to promote kidney health is surging. Therapeutic diets are essential for treating renal disease in pets, meeting other dietary needs, lowering phosphorus levels, and supporting renal function.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Hill's, Purina, Royal Canin, Blue Buffalo, Orijen, Nature's Variety, Wellness, Ziwi, Solid Gold, Taste of the Wild, and Virbac are the key manufacturers of therapeutic diets for pets. Increasing demand for therapeutic diets for the pet market among consumers has convinced manufacturers to invest heavily in the research & development of innovative and new variations of products.
Recent Developments:
The market is set to be valued at US$ 502.4 million in 2024.
The industry is marked to be valued at US$ 744.5 million by 2034.
North America is set to hold a market share of 46.8% by 2034.
Hill’s, Purina, Royal Canin, and Blue Buffalo are the prominent players in the market.
The industry is set to register a CAGR of 4.0% from 2024 to 2034.
In India, demand is anticipated to develop at a CAGR of 3.5% through 2034.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition 3. Market Background 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends by Region 3.5. Forecast Factors - Relevance & Impact 3.6. Regulations and Policies 4. Global Market- Pricing Analysis 4.1. Price Point Assessment by Region 4.1.1. Manufacturer Level Pricing 4.1.2. Distributor Level Pricing 4.1.3. Retail Level Pricing 4.2. Price Point Assessment by Pet Type 4.3. Price Forecast till 2034 5. Value Chain Analysis 5.1. Operating margins at each node of supply chain 5.2. List of Active Market Participants 6. Global Market Size in Value (US$ million) and Volume (MT) Analysis 2019 to 2023 and Forecast, 2024 to 2034 6.1. Historical Market Size in Value (US$ million) and Volume (MT) Analysis, 2019 to 2023 6.2. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis, 2024 to 2034 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Age Group 7.1. Introduction / Key Findings 7.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Age Group , 2019 to 2023 7.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast by Age Group , 2024 to 2034 7.3.1. Cat 7.3.1.1. Kitten 7.3.1.2. Adult 7.3.1.3. Senior 7.3.2. Dog 7.3.2.1. Puppy 7.3.2.2. Adult 7.3.2.3. Senior 7.4. Market Attractiveness Analysis by Age Group 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Distribution Channel, 2019 to 2023 8.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast by Distribution Channel, 2024 to 2034 8.3.1. Offline 8.3.2. Online 8.4. Market Attractiveness Analysis by Distribution Channel 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Health Condition 9.1. Introduction / Key Findings 9.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Health Condition, 2019 to 2023 9.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast by Health Condition, 2024 to 2034 9.3.1. Kidney Disease 9.3.2. Weight Management Problems 9.3.3. Arthritis and Other Orthopedic Conditions 9.3.4. Skin and/or Coat Health Problems 9.3.5. Oncology Support 9.3.6. Food Allergies 9.3.7. Diabetes and Other Endocrine Disorders 9.3.8. Gastrointestinal Issues 9.3.9. Liver Disease 9.3.10. Periodontal Disease/ Oral Health 9.3.11. Cognitive Health 9.4. Market Attractiveness Analysis by Health Condition 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. Introduction 10.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Region, 2019 to 2023 10.3. Current Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast by Region, 2024 to 2034 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East & Africa 10.4. Market Attractiveness Analysis by Region 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 11.1. Introduction 11.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 11.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 11.3.1. by Country 11.3.1.1. United States 11.3.1.2. Canada 11.3.2. by Age Group 11.3.3. by Distribution Channel 11.3.4. by Health Condition 11.4. Market Attractiveness Analysis 11.4.1. by Country 11.4.2. by Age Group 11.4.3. by Distribution Channel 11.4.4. by Health Condition 11.5. Key takeaways 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 12.1. Introduction 12.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 12.3. Market Size (US$ million) and Volume (MT) Forecast by Market Taxonomy, 2024 to 2034 12.3.1. by Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. by Age Group 12.3.3. by Distribution Channel 12.3.4. by Health Condition 12.4. Market Attractiveness Analysis 12.4.1. by Country 12.4.2. by Age Group 12.4.3. by Distribution Channel 12.4.4. by Health Condition 12.5. Key takeaways 13. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 13.1. Introduction 13.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 13.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 13.3.1. by Country 13.3.1.1. Germany 13.3.1.2. United Kingdom 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Nordic 13.3.1.8. Russia 13.3.1.9. Poland 13.3.1.10. Rest of Europe 13.3.2. by Age Group 13.3.3. by Distribution Channel 13.3.4. by Health Condition 13.4. Market Attractiveness Analysis 13.4.1. by Country 13.4.2. by Age Group 13.4.3. by Distribution Channel 13.4.4. by Health Condition 13.5. Key takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 14.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 14.3.1. by Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. by Age Group 14.3.3. by Distribution Channel 14.3.4. by Health Condition 14.4. Market Attractiveness Analysis 14.4.1. by Country 14.4.2. by Age Group 14.4.3. by Distribution Channel 14.4.4. by Health Condition 14.5. Key takeaways 15. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 15.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 15.3.1. by Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Malaysia 15.3.1.4. Indonesia 15.3.1.5. Vietnam 15.3.1.6. Philippines 15.3.1.7. Singapore 15.3.1.8. Rest of South Asia 15.3.2. by Age Group 15.3.3. by Distribution Channel 15.3.4. by Health Condition 15.4. Market Attractiveness Analysis 15.4.1. by Country 15.4.2. by Age Group 15.4.3. by Distribution Channel 15.4.4. by Health Condition 15.5. Key takeaways 16. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 16.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 16.3.1. by Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. by Age Group 16.3.3. by Distribution Channel 16.3.4. by Health Condition 16.4. Market Attractiveness Analysis 16.4.1. by Country 16.4.2. by Age Group 16.4.3. by Distribution Channel 16.4.4. by Health Condition 16.5. Key takeaways 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 17.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 17.3.1. by Country 17.3.1.1. GCC Countries 17.3.1.2. Turkiye 17.3.1.3. Egypt 17.3.1.4. South Africa 17.3.1.5. Rest of Middle East and Africa 17.3.2. by Age Group 17.3.3. by Distribution Channel 17.3.4. by Health Condition 17.4. Market Attractiveness Analysis 17.4.1. by Country 17.4.2. by Age Group 17.4.3. by Distribution Channel 17.4.4. by Health Condition 17.5. Key takeaways 18. Country-level Market Analysis, 2024 18.1. United States Market Analysis 18.1.1. by Age Group 18.1.2. by Distribution Channel 18.1.3. by Health Condition 18.2. Canada Market Analysis 18.2.1. by Age Group 18.2.2. by Distribution Channel 18.2.3. by Health Condition 18.3. Brazil Market Analysis 18.3.1. by Age Group 18.3.2. by Distribution Channel 18.3.3. by Health Condition 18.4. Mexico Market Analysis 18.4.1. by Age Group 18.4.2. by Distribution Channel 18.4.3. by Health Condition 18.5. Argentina Market Analysis 18.5.1. by Age Group 18.5.2. by Distribution Channel 18.5.3. by Health Condition 18.6. Germany Market Analysis 18.6.1. by Age Group 18.6.2. by Distribution Channel 18.6.3. by Health Condition 18.7. United Kingdom Market Analysis 18.7.1. by Age Group 18.7.2. by Distribution Channel 18.7.3. by Health Condition 18.8. France Market Analysis 18.8.1. by Age Group 18.8.2. by Distribution Channel 18.8.3. by Health Condition 18.9. Italy Market Analysis 18.9.1. by Age Group 18.9.2. by Distribution Channel 18.9.3. by Health Condition 18.10. Spain Market Analysis 18.10.1. by Age Group 18.10.2. by Distribution Channel 18.10.3. by Health Condition 18.11. BENELUX Market Analysis 18.11.1. by Age Group 18.11.2. by Distribution Channel 18.11.3. by Health Condition 18.12. Nordic Market Analysis 18.12.1. by Age Group 18.12.2. by Distribution Channel 18.12.3. by Health Condition 18.13. Russia Region Market Analysis 18.13.1. by Age Group 18.13.2. by Distribution Channel 18.13.3. by Health Condition 18.14. Poland Market Analysis 18.14.1. by Age Group 18.14.2. by Distribution Channel 18.14.3. by Health Condition 18.15. China Market Analysis 18.15.1. by Age Group 18.15.2. by Distribution Channel 18.15.3. by Health Condition 18.16. Japan Market Analysis 18.16.1. by Age Group 18.16.2. by Distribution Channel 18.16.3. by Health Condition 18.17. South Korea Market Analysis 18.17.1. by Age Group 18.17.2. by Distribution Channel 18.17.3. by Health Condition 18.18. India Market Analysis 18.18.1. by Age Group 18.18.2. by Distribution Channel 18.18.3. by Health Condition 18.19. Thailand Market Analysis 18.19.1. by Age Group 18.19.2. by Distribution Channel 18.19.3. by Health Condition 18.20. Malaysia Market Analysis 18.20.1. by Age Group 18.20.2. by Distribution Channel 18.20.3. by Health Condition 18.21. Indonesia Market Analysis 18.21.1. by Age Group 18.21.2. by Distribution Channel 18.21.3. by Health Condition 18.22. Vietnam Market Analysis 18.22.1. by Age Group 18.22.2. by Distribution Channel 18.22.3. by Health Condition 18.23. Philippines Market Analysis 18.23.1. by Age Group 18.23.2. by Distribution Channel 18.23.3. by Health Condition 18.24. Singapore Market Analysis 18.24.1. by Age Group 18.24.2. by Distribution Channel 18.24.3. by Health Condition 18.25. Australia Market Analysis 18.25.1. by Age Group 18.25.2. by Distribution Channel 18.25.3. by Health Condition 18.26. New Zealand Market Analysis 18.26.1. by Age Group 18.26.2. by Distribution Channel 18.26.3. by Health Condition 18.27. GCC Countries Market Analysis 18.27.1. by Age Group 18.27.2. by Distribution Channel 18.27.3. by Health Condition 18.28. Turkiye Market Analysis 18.28.1. by Age Group 18.28.2. by Distribution Channel 18.28.3. by Health Condition 18.29. Egypt Market Analysis 18.29.1. by Age Group 18.29.2. by Distribution Channel 18.29.3. by Health Condition 18.30. South Africa Market Analysis 18.30.1. by Age Group 18.30.2. by Distribution Channel 18.30.3. by Health Condition 19. Market Structure Analysis 19.1. Global Market Competition - a Dashboard View 19.2. Industry Structure Analysis 19.2.1. % tier 1 market players 19.2.2. % tier 2 market players 19.2.3. % tier 3 market players 19.3. Global Market Company Share Analysis 19.3.1. For Tier 1 Market Players, 2023 19.3.2. Company Market Share Analysis of Top 5 Players, by Region 19.4. Key Participants Market Presence (Intensity Mapping) by Region 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Hill’s 20.3.1.1. Age Group Portfolio 20.3.1.2. Distribution Channel 20.3.1.3. Revenue by Market Segments (Age Group/Channel/Region) 20.3.1.4. Sales Footprint 20.3.1.5. Strategy Overview 20.3.1.5.1. Marketing Strategy 20.3.1.5.2. Age Group Strategy 20.3.1.5.3. Channel Strategy 20.3.1.6. SWOT Analysis 20.3.1.7. Purina 20.3.1.8. Royal Canin 20.3.1.9. Blue Buffalo 20.3.1.10. Orijen 20.3.1.11. Nature’s Variety 20.3.1.12. Wellness 20.3.1.13. Ziwi 20.3.1.14. Solid Gold 20.3.1.15. Taste of the Wild 20.3.1.16. Virbac 21. Assumption & Acronyms 22. Research Methodology
Explore Food and Beverage Insights
View Reports
Therapeutic Diet for Pet Market
